van Deventer H - Search Results

1

CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease.

Coghill JM, Fowler KA, West ML, Fulton LM, van Deventer H, McKinnon KP, Vincent BG, Lin K, Panoskaltsis-Mortari A, Cook DN, Blazar BR, Serody JS. Coghill JM, et al. Among authors: van deventer h. Blood. 2013 Aug 1;122(5):825-36. doi: 10.1182/blood-2012-06-435735. Epub 2013 Jun 24. Blood. 2013. PMID: 23798714 Free PMC article.

2

Transfection of macrophage inflammatory protein 1 alpha into B16 F10 melanoma cells inhibits growth of pulmonary metastases but not subcutaneous tumors.

van Deventer HW, Serody JS, McKinnon KP, Clements C, Brickey WJ, Ting JP. van Deventer HW, et al. J Immunol. 2002 Aug 1;169(3):1634-9. doi: 10.4049/jimmunol.169.3.1634. J Immunol. 2002. PMID: 12133994

3

C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis.

van Deventer HW, O'Connor W Jr, Brickey WJ, Aris RM, Ting JP, Serody JS. van Deventer HW, et al. Cancer Res. 2005 Apr 15;65(8):3374-9. doi: 10.1158/0008-5472.CAN-04-2616. Cancer Res. 2005. PMID: 15833871

4

C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.

van Deventer HW, Wu QP, Bergstralh DT, Davis BK, O'Connor BP, Ting JP, Serody JS. van Deventer HW, et al. Am J Pathol. 2008 Jul;173(1):253-64. doi: 10.2353/ajpath.2008.070732. Epub 2008 Jun 5. Am J Pathol. 2008. PMID: 18535183 Free PMC article.

5

The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.

van Deventer HW, Burgents JE, Wu QP, Woodford RM, Brickey WJ, Allen IC, McElvania-Tekippe E, Serody JS, Ting JP. van Deventer HW, et al. Cancer Res. 2010 Dec 15;70(24):10161-9. doi: 10.1158/0008-5472.CAN-10-1921. Cancer Res. 2010. PMID: 21159638 Free PMC article.

6

Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2.

van Deventer HW, Palmieri DA, Wu QP, McCook EC, Serody JS. van Deventer HW, et al. J Immunol. 2013 May 1;190(9):4861-7. doi: 10.4049/jimmunol.1202857. Epub 2013 Mar 27. J Immunol. 2013. PMID: 23536638 Free PMC article.

7

C-C chemokine receptor 5 on pulmonary mesenchymal cells promotes experimental metastasis via the induction of erythroid differentiation regulator 1.

Mango RL, Wu QP, West M, McCook EC, Serody JS, van Deventer HW. Mango RL, et al. Mol Cancer Res. 2014 Feb;12(2):274-82. doi: 10.1158/1541-7786.MCR-13-0164. Epub 2013 Nov 6. Mol Cancer Res. 2014. PMID: 24197118 Free PMC article.

8

Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.

Tschernia NP, Kumar V, Moore DT, Vincent BG, Coombs CC, Van Deventer H, Foster MC, DeZern AE, Luznik L, Riches ML, Serody JS, Gojo I, Zeidner JF. Tschernia NP, et al. Among authors: van deventer h. Transplant Cell Ther. 2021 Dec;27(12):1021.e1-1021.e5. doi: 10.1016/j.jtct.2021.08.022. Epub 2021 Aug 30. Transplant Cell Ther. 2021. PMID: 34474164 Free article. Clinical Trial.

9

Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.

Zeidner JF, Vincent BG, Ivanova A, Moore D, McKinnon KP, Wilkinson AD, Mukhopadhyay R, Mazziotta F, Knaus HA, Foster MC, Coombs CC, Jamieson K, Van Deventer H, Webster JA, Prince GT, DeZern AE, Smith BD, Levis MJ, Montgomery ND, Luznik L, Serody JS, Gojo I. Zeidner JF, et al. Among authors: van deventer h. Blood Cancer Discov. 2021 Sep 10;2(6):616-629. doi: 10.1158/2643-3230.BCD-21-0070. eCollection 2021 Nov. Blood Cancer Discov. 2021. PMID: 34778801 Free PMC article. Clinical Trial.

10

Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.

Vincent BG, File DM, McKinnon KP, Moore DT, Frelinger JA, Collins EJ, Ibrahim JG, Bixby L, Reisdorf S, Laurie SJ, Park YA, Anders CK, Collichio FA, Muss HB, Carey LA, van Deventer HW, Dees EC, Serody JS. Vincent BG, et al. Among authors: van deventer hw. J Immunol. 2023 Jul 15;211(2):219-228. doi: 10.4049/jimmunol.2300077. J Immunol. 2023. PMID: 37204246 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page